Gary H. Lyman

Biography

Dr. Gary Lyman is co-director of the Hutchinson Institute for Cancer Outcomes Research and member of the Public Health Sciences and Clinical Research Divisions at the Fred Hutchinson Cancer Research Center. Dr. Lyman is a professor of medicine at the University of Washington School of Medicine and an adjunct professor in the School of Public Health and School of Pharmacy at the University of Washington. Dr. Lyman is a board certified medical oncologist and hematologist and has practiced in these specialties for more than 30 years. He is a member of the Breast Cancer Program at the Seattle Cancer Care Alliance. Dr. Lyman received his undergraduate and medical degree from the State University of New York in Buffalo and completed his internal medicine residency at the University of North Carolina in Chapel Hill and completed a hematology/oncology fellowship at the Roswell Park Memorial Institute. Dr. Lyman also pursued a postdoctoral fellowship in biostatistics at the Harvard School of Public Health and the Dana Farber Cancer Center. Previously, Dr. Lyman was a professor of medicine, epidemiology and biostatistics and associate chair of medicine at the University of South Florida and served as chief of medicine and as program director for the Division of Oncology for 15 years at the Moffitt Cancer Center in Tampa, Florida. He was also an associate chairman of the Department of Medicine at USF. Dr. Lyman subsequently has held positions as a Thomas Ordway Endowed Professor of Medicine and Cancer Center director at the Albany Medical College and professor of epidemiology and biostatistics at SUNY Albany. He subsequently served as a professor of medicine and the Cancer Center associate director and director of Health Services and Outcomes Research at the University of Rochester and Strong Memorial Hospital. Prior to relocating to his current position, Dr. Lyman served as professor of medicine and director of Comparative Effectiveness and Outcomes Research at Duke University School of Medicine and the Duke Cancer Institute and a senior fellow at the Duke Center for Clinical Health Policy Research. Dr. Lyman is a fellow of several professional societies, including the Royal College of Physicians (Edinburg), the American Society of Clinical Oncology, the American College of Clinical Pharmacology and the American College of Preventive Medicine. Additionally, Lyman is editor-in-chief of Cancer Investigation and serves on the editorial board of the Journal of Clinical Oncology and the Journal of Global Oncology along with several other professional journals. Dr. Lyman is active in leadership roles in the American Society of Clinical Oncology where he chairs multiple clinical practice guidelines and serves on the board of directors and several committees. Dr. Lyman received the ASCO Statesmen Award in 2010 and was recognized by Newsweek in 2015 as a Top Cancer Doctor.

Research Interest

Research interests include personalized cancer supportive care, comparative effectiveness and outcomes research related to biomarkers and targeted therapies, mathematical and statistical prognostic and predictive models, advanced methods of evidence synthesis in support of clinical practice guidelines and population studies of patterns of cancer treatment and the impact of health disparities on the quality of cancer care delivery and outcomes. Other research interests include health economics, pharmacoeconomics and healthcare policy as well as cancer treatment and supportive care in the elderly.